[Oral anticoagulation using coumarins - an update]

Area of Science:

• Cardiology
• Neurology
• Pharmacology

Background:

• Vitamin K antagonists (VKAs) are essential for managing thrombotic and thromboembolic disorders.
• Key indications include venous thrombosis, pulmonary embolism, atrial fibrillation, and mechanical heart valve replacement.
• These anticoagulants are highly relevant in cardio-neurological practice.

Purpose of the Study:

• To provide a comprehensive overview of Vitamin K antagonists (VKAs).
• To focus on the mode of action, indications, and efficacy of VKAs.
• To discuss practical treatment aspects, side effects, and monitoring of VKAs.

Main Methods:

• Literature review and synthesis of current evidence on VKAs.
• Analysis of clinical guidelines and practice recommendations.
• Focus on practical application in neurological and cardiological settings.

Main Results:

• VKAs effectively prevent and treat thromboembolic events across various indications.
• Understanding VKA's mechanism is key to optimizing therapeutic outcomes.
• Careful monitoring and management of side effects are crucial for patient safety.

Conclusions:

• Vitamin K antagonists remain vital in managing thromboembolic conditions, particularly in patients with atrial fibrillation and mechanical heart valves.
• Neurologists require a thorough understanding of VKA therapy for effective cardio-neurological patient care.
• Optimal VKA treatment involves balancing efficacy with vigilant monitoring and side effect management.